Default Category
-
Pluggin In the Consumer: The Adoption of Electrically Powered Vehicles in the U.S.
Ofek, Elie; Ribatt, Polly RossCase HBS-510076-EMarketingHow will U.S. consumers respond to the proliferation of alternative-fuel vehicles, such as cars powered partially or completely by electricity, in the coming decade? After a century in which fossil-fuel-powered vehicles dominated the market, it appeared consumers would have an unprecedented level of choice as to the type of car they purchased and drove. Automakers were introducing various models that used electricity for power, and other power so...Starting at €8.20
-
Oversight Systems
Cespedes, Frank V.; Migdal, AmramCase HBS-817015-EMarketingThe case, set in May 2016, discusses sales strategy and managing sales and service at Oversight Systems, an Atlanta, Georgia-based software firm that developed analytics for organizations to monitor their data for errors, fraud, and operational inefficiencies. Included is an overview of Oversight's founding and the evolution of its offering from customized software analytics to pre-packaged software-as-a-service (SaaS) bundles, called Insights on...Starting at €8.20
-
Formlabs: Selling a New 3D Printer
Cespedes, Frank V.; Hull, Olivia; Migdal, AmramCase HBS-817001-EMarketingHeadquartered in Somerville, Massachusetts, Formlabs manufactures 3D printers used to print everything from prototypes and models to jewelry, dental, and sculpture molds. As Formlabs prepares to ship its latest model, the Form 2, Head of Customer Development and Services Luke Winston wonders which strategy will double sales. Should he focus on direct sales or add more channel partners?Starting at €8.20
-
Tengion: Bringing Regenerative Medicine to Life
Ofek, Elie; Ribatt, Polly RossCase HBS-510031-EMarketingTengion is a young biotech company that is at the frontier of regenerative medicine; a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late 2008 Tengion management faces a difficult dilemma. In light of the financial crises, the company needs to manage cash burn by prioritizing its R&D efforts. CEO Nichtberger needs t...Starting at €8.20